Easton Pharmaceuticals Announces It has Entered into Discussions For Distribution Agreement In East Asia

Posted by on Sep 15, 2011 in News | 0 comments

TORONTO, ONTARIO–(Marketwire -09/15/11)- Easton Pharmaceuticals Inc (Pinksheets: EAPH.PK – News), a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products announced today the company has entered Into Discussions with 2 groups to distribute Viorra In South East Asia and surrounding markets.

As is the case in Mexico and other Latin American markets, East Asia represents a huge opportunity for VIORRA and the companies various other products based around its proprietary transdermal delivery system.

East Asia possesses a population upwards of 4 Billion people. The over-the-counter aspect of VIORRA and the fact the product possesses ingredients classified by the FDA as generally regarded as safe (GRAS) has transformed VIORRA into a very appealing product to people in these markets who repeatedly use over-the-counter products / herbal remedies more frequently than in North America. Products such as this have wide appeal and attraction to East Asian culture, which includes large markets such as China and India.

Presently the company has entered into discussions with two groups for the sale and distribution of VIORRA. Any agreements will involve an upfront payment to Easton, presently being discussed by all parties.

Leave a Reply

Your email address will not be published. Required fields are marked *

* Copy This Password *

* Type Or Paste Password Here *